Marimed Inc

Good morning, my name is Jenny, and I will be your conference operator today. At this time, I would like to welcome everyone to the Merrimid Second Quarter 2024 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star, then the number 1 on your telephone keypad. If you would like to withdraw your question, please press star, then the number 2. Thank you. I will now turn the line over to Mr. Steve Blust, Vice President of Investor Relations, to begin the conference. Please go ahead.

Good morning, everyone, and welcome to Merrimid's second quarter 2024 earnings call. Joining me today are John Levine, our Chief Executive Officer. and Ryan Crandall, our Chief Revenue Officer. This call will be archived on our investor relations website and contains forward-looking statements. Actual events or results may differ materially from these forward-looking statements and are subject to various risks and uncertainties. The discussion of some of these risks is in the risk factors section of our 10-K available on our website. Any forward-looking statements reflect management's expectations as of today, and we assume no obligation to update them unless required by law. Additionally, we will refer to certain non-GAAP financial measures which are reconciled in our earnings release. Finally, our third quarter 2024 earnings release is tentatively scheduled to be issued after the markets close on November 6th, and our analyst call is tentatively scheduled to be held the morning of November 7th at 8 a.m.

I will now turn the call over to John. Thank you, Steve, and good morning, everyone.